Everolimus
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| F6140-5MG | 5 mg | 75,00 | Add | |
| F6141-25MG | 25 mg | 219,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Please inquire a quote for two or more UBPBio products
Everolimus is a derivative of sirolimus and works as an inhibitor of mammalian target of rapamycin (mTOR). It has been approved by the FDA for use in the treatment of certain breast cancer, pancreatic cancer, renal cell cancer and other tumours. Also, it is used as an immunosuppressant to prevent rejection of organ transplants.
| Category | Inhibitor |
| Supplier | UBPBio |
| Regulatory Status | RUO |
| Format | Powder; no buffer |
| CAS-Number | 159351-69-6 |
| Storage Conditions | -20°C |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.ubpbio.com |
| Shipping Details | Ambient temp. |
| Material Safety Data Sheet | Download PDF |
